Jump to navigation
By Dr. Jon Andrus, Executive Vice President of the Sabin Vaccine Institute and Director of the Vaccine Advocacy and Education Program
This blog was originally published by the Dengue Vaccine Initiative.
In its efforts to share first-hand testimonials from dengue-endemic countries, the Dengue Vaccine Initiative (DVI) asked Dr.
Dr. Capeding led the first Phase 3 trial ever completed for a dengue vaccine candidate.